Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?

This publication has 22 references indexed in Scilit:

• The Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease Patients
  The Journal of Clinical Psychiatry, 1999
• Molecular Physiology, Biochemistry, and Pharmacology of Alzheimer's Amyloid Precursor Protein (APP)
  Annals of the New York Academy of Sciences, 1996
• Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
  Published by Elsevier ,1996
• Cholinesterase inhibitors increase secretion of APPs in rat brain cortex
  NeuroReport, 1995
• Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine Receptors
  Science, 1992
• Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert
  Molecular Brain Research, 1991
• Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
  Drug Development Research, 1988
• The effects of physostigmine on acetylcholinesterase activity of CSF, plasma and brain. A comparison of intravenous and intra ventricular administration in beagle dogs
  Neuropharmacology, 1986
• Molecular forms of cholinesterases in cerebrospinal fluid, blood plasma, and brain tissue of the beagle dog
  Journal of Neuroscience Research, 1979
• Acetylcholinesterase activity in ventricular and cisternal csf of dogs: Effect of chlorpromazine
  Journal of Neuroscience Research, 1978